Wuxi Bio (02269.HK) held a board of directors meeting on August 21 to consider and approve the interim performance.
Wuxi Bio (02269.HK) announced that the board of directors will convene a meeting in Hong Kong on August 21, 2024 (Wednesday) to consider and approve the interim performance of the group for the six months ending June 30, 2024 (including).
WUXI BIO: DATE OF BOARD MEETING
Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$23.25 From HK$53.65, Keeps at Buy
Wuxi Biologics Stock Looks Undervalued -- Market Talk
Zhongjin Securities in "Dahang": It is recommended to wait for a sufficient correction before entering the high dividend theme. In the short term, we are bullish on the semiconductors, automobiles, media and entertainment, software, and biotechnology sect
According to a report by CICC, the Hong Kong stock market rebounded briefly last week, with the HSI reaching 18,000 points again, driven by increased expectations of a rate cut by the US Federal Reserve.
Quick glance at the market | Hong Kong stocks opened high and fell, resource stocks such as oil, coal, and non-ferrous metals weakened, and Sunny Optical Technology fell nearly 7%.
As of the time of writing, the Hang Seng Index fell by 0.39%, the Guo Index fell by 0.47%, and the Ke Index fell by 0.01%. Network technology stocks showed mixed gains and losses, with Meituan up nearly 3%, Xiaomi Group up over 1%, and Tencent up nearly 1%; Sensetime fell over 6%, Bilibili fell by nearly 3%, while Baidu and Kuaishou saw slight drops.